Abstract 4723: Innovative cancer treatment of human lung cancer cells PC-9 with a synthetic retinoid Am80 and EGCG via inhibition of HDAC4 and HDAC5
Masami Suganuma(Saitama University), Hirota Fujiki(National Cancer Centre Japan), Anchalee Rawangkhan(Saitama University), Sonthaya Umsumarng(Saitama Cancer Center), Ryo Sakai(KU Leuven), Keisuke Iida(Hyogo Prefectural Awaji Medical Center), Koichi Shudo(The University of Tokyo), Yukiko Oya(Saitama Cancer Center), Hiroyuki Kagechika(The University of Tokyo)
Cited by 3
Related Papers
Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR
|Journal of Cancer Research and Clinical Oncology|1992|807
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
|Cancer Cell|2018|718
Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter.
|Proceedings of the National Academy of Sciences|1988|602
Preventive effects of drinking green tea on cancer and cardiovascular disease: Epidemiological evidence for multiple targeting prevention
|BioFactors|2000|408
Tumor Promotion by Inhibitors of ProteinZ Phosphatases 1 and 2A: The Okadaic Acid Class of Compounds
|Advances in cancer research|1993|310